EXICURE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EXICURE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $4.00K, a 96.95% decline year-over-year.
- EXICURE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2021-06-30 was $131.00K.
- EXICURE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $5.00K, a 97.61% decline from fiscal 2021.
- EXICURE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $209.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2022-12-31 | $5.00K 10-K · filed 2024-06-06 | |
| 2022-06-30 | $4.00K 10-Q/A · filed 2024-06-06 | |
| 2021-12-31 | $209.00K 10-K · filed 2023-03-27 | |
| 2021-06-30 | $131.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |